Sex differences in microvascular function and arterial hemodynamics in nondialysis chronic kidney disease

Danielle L Kirkman1, Meghan G Ramick2, Bryce J Muth3

  • 1Department of Kinesiology and Health Sciences, Virginia Commonwealth University, Richmond, Virginia.

Insights

Older female patients with chronic kidney disease (CKD) exhibit poorer arterial hemodynamics and impaired microvascular function compared to males. Oxidative stress appears to contribute to these sex-based differences in vascular dysfunction in CKD.

Area of Science:

  • Cardiovascular Physiology
  • Nephrology
  • Vascular Biology

Background:

  • Cardiovascular disease (CVD) is a primary cause of mortality in chronic kidney disease (CKD).
  • Abnormal arterial hemodynamics and microvascular dysfunction are implicated in CVD development within CKD populations.
  • Limited data exist on sex-specific differences in vascular function in nondialysis CKD patients.

Purpose of the Study:

  • To investigate potential sex differences in arterial hemodynamics and microvascular function in patients with stages 3-4 CKD.
  • To explore the role of oxidative stress in mediating microvascular dysfunction in female CKD patients.

Main Methods:

  • Vascular function was assessed in 22 males and 10 females with CKD stages 3-4.
  • Arterial hemodynamics were measured using tonometry and oscillometry.
  • Microvascular function was evaluated using skin blood flow measurements with microdialysis and laser-Doppler flowmetry, assessing responses to Tempol and apocynin.

Main Results:

  • Female CKD patients exhibited significantly higher central pulse pressure and augmentation index compared to males.
  • Cutaneous vascular function was reduced in females (77%) versus males (89%).
  • Microvascular function in females improved with Tempol and apocynin, suggesting a role for oxidative stress, while males showed no significant improvement.

Conclusions:

  • Female patients with nondialysis CKD demonstrate poorer central hemodynamics and reduced microvascular function compared to male counterparts.
  • Oxidative stress likely contributes to the observed microvascular dysfunction in older females with CKD.
  • These findings highlight potential sex-specific therapeutic targets for cardiovascular risk reduction in CKD.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
64
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
216
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
56
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
24
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
42
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
135